Search

everythinglearnresearchcommunity

for

Search:↓

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

JAK inhibitors show promise in treating difficult skin diseases.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride may reduce insulin sensitivity and increase body fat.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

Increased ODC activity leads to skin tumors by recruiting stem cells, not by toxic byproducts.

Regulatory challenges make developing combination therapies in urology difficult and costly.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Finasteride helps female-pattern hair loss.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

A new compound may treat benign prostatic hyperplasia better than finasteride.

IND-Ca ointment effectively reduces inflammation with minimal skin irritation.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Drugs like PDEI may help hair disorders like AGA.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.